ArticleJournal for immunotherapy of cancer2020

FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.

Lucia Campos Carrascosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.